- Professor, CWRU School of Medicine
James Liu, MD joined University Hospitals Cleveland Medical Center in 2001 as the Department of Obstetrics and Gynecology Chair. Before joining UH CMC, Dr. Liu was the REI division director and fellowship program director at the University of Cincinnati for more than a decade.
Dr. Liu is an internationally known expert in hormonal changes associated with aging and therapeutic hormone effects during menopause.
He has extensive translation and clinical research experience. He has been the principal investigator on multiple National Institute of Health (NIH) and industrial grants, including the Women's Health Initiative and the National Institute of Child Health and Human Development (NICHD) Clinical Contraceptive Trials Network. His clinical areas of interest include menopausal medicine, osteoporosis, infertility, and assisted reproductive techniques. He is an active clinician and serves as a clinical, infertility surgery, and research mentor.
- In Vitro Fertilization
- Menopause Management
- Reproductive Endocrinology and Infertility
- Reproductive Endocrinology/Infertility - American Board of Obstetrics and Gynecology
- Obstetrics and Gynecology - American Board of Obstetrics and Gynecology
Fellowship | Reproductive Endocrinology
Reproductive Endocrinology - University Of California San Diego Medical Center (1981 - 1983)
Residency | Obstetrics and Gynecology
Obstetrics and Gynecology - Strong Memorial Hospital Of The University Of Rochester Medical Center (1978 - 1981)
Internship | Obstetrics and Gynecology
Obstetrics and Gynecology - Strong Memorial Hospital Of The University Of Rochester Medical Center (1977 - 1978)
The Ohio State University College Of Medicine (1977)
The Ohio State University (1974)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, James Liu disclosed the following Outside Relationships with Industry:
- - Decile Ten, LLC - Consulting
- - Ferring International - Consulting